Arena Pharmaceuticals Stock News

NEW YORK, Dec. 15, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties

Arena Pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a result, the market for late-stage oral IBD candidates that big pharma can acquire is thinning.

Even more gains could lie ahead for the vaccine maker's investors.

Source: Streetwise Reports 12/13/2021 Arena Pharmaceuticals shares traded 80% higher after the company reported it agreed to be acquired by Pfizer Inc. for $100.00 per share in cash in a deal valued at $6.7 billion. Clinical stage pharmaceutical company Arena Pharmaceuticals Inc. (ARNA:NASDAQ), today announced that it entered into a definitive agreement to be acquired []

The Zacks Analyst Blog Highlights: Pfizer, Arena Pharma, Merck, Jazz Pharm and Sanofi

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) with the stream of 2.13% also noticed, India Johnson & Johnson (NYSE:JNJ) encountered a rapid change of 1.09% in the last hour of Tuesdays trading session. The post Sizzling Stock: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Johnson & Johnson (NYSE:JNJ) appeared first on Stocks Equity .

This article was originally published on TipRanks.com. The post Arena Pharmaceuticals Soars 80.4% on Pfizer’s $6.7B Acquisition Deal appeared first on Smarter Analyst .

Pfizer made a big splash in the M&A space Monday, announcing a $6.7 billion buyout of Arena Pharmaceuticals to chase Bristol Myers Squibb in the S1P race. But company execs suggested the company isn’t finished bringing on new assets. In an investor call outlining the Arena acquisition, chief business innovation

WILMINGTON, Del., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Arena Pharmaceuticals Inc. (Arena) (NASDAQ GS: ARNA ) regarding possible breaches of fiduciary duties and other violations of law related to Arenas agreement to be acquired by Pfizer Inc. (NYSE: PFE ). Under the terms of the agreement, Arenas shareholders will receive $100.00 in cash for each share of Arena common stock they own.

Companies In The News Are: ARNA, PFE, LLY, FHTX, TPX, NAVI.

The Pfizer (PFE)-Arena (ARNA) deal raises hopes that M&A activity will pick up significantly in 2022. as big drugmakers are sitting on huge piles of cash.

Pfizer (PFE) signs an agreement to acquire Arena Pharmaceuticals for $6.7 billion in cash. Stock rises.

Pfizer Inc. said Monday it has agreed to acquire Arena Pharmaceuticals Inc. in a deal with a value of about $6.7 billion, sending Pfizer shares to their highest close ever, and Arena shares to their l

Pfizer (PFE) signs an agreement to acquire Arena Pharmaceuticals for $6.7 billion in cash. Stock rises.

The Pfizer (PFE)-Arena (ARNA) deal raises hopes that M&A activity will pick up significantly in 2022. as big drugmakers are sitting on huge piles of cash.